Clinical Trials
6 trialsNCT07005102 2026-05-22
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
AbbVie
Phase 2/3 Recruiting
NCT06989437 2026-05-20
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Pfizer
Phase 2/3 Recruiting
NCT07112196 2026-05-20
VINCIT
CatalYm GmbH
Phase 2/3 Recruiting
NCT06800092 2026-05-11
SPARC
The University of Texas Medical Branch, Galveston
Phase 2/3 Not yet recruiting
NCT07000253 2026-05-07
OMEC-5
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2/3 Recruiting
NCT06085716 2026-05-05
Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers
M.D. Anderson Cancer Center
Phase 2/3 Recruiting